Registry of Pregnancies Exposed to Chemo
The University of Pittsburgh registry of pregnancies exposed to cancer chemotherapy now has more than 260 cases on file. The registry, a summary of published and unpublished outcomes of such pregnancies, is available to expedite counseling for concerned patients and clinicians who may face dilemmas in weighing the benefits of cancer therapy against the risks of teratogenicity.
The University of Pittsburgh registry of pregnancies exposed tocancer chemotherapy now has more than 260 cases on file. The registry,a summary of published and unpublished outcomes of such pregnancies,is available to expedite counseling for concerned patients andclinicians who may face dilemmas in weighing the benefits of cancertherapy against the risks of teratogenicity.
For further information, contact Dr. John J. Mulvihill or BetsyGettig, Department of Human Genetics, University of Pittsburgh,Pittsburgh, PA 15261. Phone: 412-624-9951; fax: 412-624-3020;e-mail: jmulvihi@helix.hgen.pitt.edu.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
![We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2Fd5a069c33bbfe917bc7c0b1bb13d76c0a815cc44-234x234.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "We must work on clinical predictors based on the disease phenotype, we must work on the physician’s attitude, and [we must work to] stimulate the correct and timely usage of ruxolitinib.")
